Eric J. Whitman
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Melanoma and MAPK Pathways 3
- Protein Degradation and Inhibitors 1
- Cell death mechanisms and regulation 1
-
- Prostate Cancer Diagnosis and Treatment 2
- Co-authors
- Bungo Furusato (3 shared papers)Amina Ali (3 shared papers)Stephen A. Brassell (3 shared papers)John F. Ward (1 shared paper)David H. Lawson (2 shared papers)Shiv Srivastava (3 shared papers)Lee D. Cranmer (3 shared papers)Yongmei Chen (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)The Journal of Urology (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)
- Partner nations
- United States
In The Last Decade
Eric J. Whitman
8 papers receiving 360 citations
Peers
Comparison fields: 5 of 56
- Pulmonary and Respiratory Medicine 161
- Cancer Research 73
- Oncology 78
- Molecular Biology 161
- Immunology 21
Countries citing papers authored by Eric J. Whitman
This map shows the geographic impact of Eric J. Whitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Whitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Whitman more than expected).
Fields of papers citing papers by Eric J. Whitman
This network shows the impact of papers produced by Eric J. Whitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Whitman. The network helps show where Eric J. Whitman may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric J. Whitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 129 | |
| 2 | 2009 | 113 | |
| 3 | 2010 | 43 | |
| 4 | 2009 | 35 | |
| 5 | 2010 | 29 | |
| 6 | 2007 | 6 | |
| 7 | 2007 | 6 | |
| 8 | A phase II study of YM155 administered as 168 hour continuous infusion in stage IV and unresectable stage III melanoma. | 2007 | 4 |
About Eric J. Whitman
Eric J. Whitman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Organic Chemistry and Computational Theory and Mathematics, having authored 8 papers that have together received 365 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Click Chemistry and Applications (1 paper), Computational Drug Discovery Methods (1 paper), Immunotherapy and Immune Responses (1 paper), Protein Degradation and Inhibitors (1 paper), Cutaneous Melanoma Detection and Management (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (161 citations), Cancer Research (73 citations), Oncology (78 citations), Molecular Biology (161 citations) and Immunology (21 citations). Eric J. Whitman has collaborated with scholars based in United States. Frequent co-authors include Bungo Furusato, Amina Ali, Stephen A. Brassell, John F. Ward, David H. Lawson, Shiv Srivastava, Lee D. Cranmer, Yongmei Chen, John M. Kirkwood and Joseph Catlett. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Investigational New Drugs, The Journal of Urology and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.